PEN penumbrainc.com: Market Value

Penumbra, Inc. (PEN) enjoys the absolute trust of physicians due to its cutting-edge thrombosis treatment methods. However, the risk of product obsolescence driven by innovations from tech giants remains significant, and the market capitalization stands at 12.68. This price chart clearly demonstrates the market dynamics of this manufacturer. The business relies on creating a closed ecosystem of neurovascular tools, where staff training ensures high clinic loyalty to the brand.

PEN (penumbrainc.com) Market Value history from 07/04/2022 to 11/12/2026

PEN (Penumbra Medical): analytical breakdowns and indicator data

- current price and projected stock value:

Stock Price Penumbra|PEN - Average Forecast Price

- company stock capitalization data:

Market Value Penumbra Medical|PEN - Business Value

- book value of equity indicators:

Accounting Value per Share Penumbra|PEN - Total Net Assets|Market Capitalization to Book Value Ratio penumbrainc.com|PEN - Aggregate Asset Value

- company total debt and liquidity indicators:

- net income and valuation multiples indicators:

PEN - Company Net Income|Future Profit Penumbra, Inc.|PEN - P/E Multiple|Projected Price to Earnings Penumbra Corp|PEN - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Penumbra Medical|PEN - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Penumbra|PEN - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months penumbrainc.com|PEN - Earnings per share increase in current year|Net earnings per share growth forecast for next year Penumbra, Inc.

Summary company analysis:Penumbra PEN

The market capitalization, which has reached 12.68, aggregates the value of all shares to determine the market scale of the business, allowing the investor to compare asset value with actual cash flows. By analyzing the current aggregate capitalization of the issuer, one can confirm the fundamental stability of Penumbra, Inc., whose innovations in vascular surgery are shielded from geopolitical risks and trade restrictions, ensuring stable value growth.

Competitors of Penumbra, Inc.